Mexiletine as an adjuvant analgesic for the management of neuropathic cancer pain

Anesthesia and Analgesia

Volumn 89, Issue 3, 1999, Pages 760-761

  Sloan, Paul ^a,d   Basta, Mafdy ^a   Storey, Porter ^b   Von Gunten, Charles ^c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b EAST TEXAS MEDICAL CENTER   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEXILETINE; MORPHINE;

ADULT; ANALGESIA; ARTICLE; ATAXIA; CANCER PAIN; CASE REPORT; COLON ADENOCARCINOMA; FEMALE; HUMAN; LUNG ADENOCARCINOMA; METASTASIS; NAUSEA; NEUROPATHY; NYSTAGMUS; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PRIORITY JOURNAL; TREMOR; UTERUS CARCINOMA; VERTIGO; VOMITING;

ADENOCARCINOMA; ANALGESICS, NON-NARCOTIC; COLONIC NEOPLASMS; FEMALE; HUMANS; LUMBOSACRAL PLEXUS; LUNG NEOPLASMS; MEXILETINE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS; PAIN MEASUREMENT; PAIN, INTRACTABLE; UTERINE NEOPLASMS;

EID: 0032840474     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199909000-00044     Document Type: Article

References (12)

1. Bowsher D. Neurogenic pain: diagnosis and treatment. Med Times 1989;117:21-6.
2. Stracke H, Myer V, Schumacher H, Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 1992;15:1550-5.
3. Chabal C, Jacobson L, Mariano A, et al. The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992;76:513-7.
4. Awerbuch GL. Mexiletine for thalamic pain syndrome. Int J Neurosci 1990;55:129-33.
5. Sloan PA, Hodes J, John W. Radiosurgical pituitary ablation for cancer pain. J Palliative Care 1996;12:51-3.
6. Carpenter JS, Androykowski MA, Sloan PA, et al. Postmastectomy/lumpectomy pain in breast cancer survivors. J Clin Epidemiol 1998;51:1285-92.
7. Billings JA. Palliative medicine update: neuropathic pain. J Palliative Care 1994;10:40-3.
8. Lathers CM, O'Rourke DK. Antiarrhythmic agents. In: Smith CM, Reynard AM, eds. Textbook of pharmacology. Philadelphia: WB Sanders, 1992:539.
9. Tanelian DL, Maciver MB. Analgesic concentrations of lidocaine suppress tonic A- delta and C fiber discharges produced by acute injury. Anesthesiology 1991;74:934-6.
10. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992;48:261-8.
11. Chong SF, Bretscher ME, Mailliard JA, et al. Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer. J Pain Symptom Manage 1997;13:112-7.
12. Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991;45:145-8.